ATYR
Price
$6.77Alerts
Change
-$0.79 (-10.45%)
Updated
Nov 11 closing price
Capitalization
622.86M
126 days until earnings call
Intraday BUY SELL Signals
IDYA
Price
$32.72Alerts
Change
+$0.97 (+3.06%)
Updated
Nov 11 closing price
Capitalization
3.01B
103 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATYR vs IDYA

ATYR vs IDYA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ATYR vs. IDYA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Buy and IDYA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATYR with price predictions
Nov 11, 2026

ATYR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ATYR turned positive on October 23, 2026. Looking at past instances where ATYR's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ATYR's RSI Indicator exited the oversold zone, 27 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on ATYR as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

Following a +25.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATYR advanced for three days, in 201 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

ATYR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATYR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ATYR entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.767) is normal, around the industry mean (3.498). P/E Ratio (-10.079) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (196.078) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. ATYR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATYR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for IDYA with price predictions
Nov 11, 2026

IDYA's RSI Oscillator ascends from oversold territory

The RSI Oscillator for IDYA moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 32 of the 33 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 63 cases where IDYA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for IDYA just turned positive on November 11, 2026. Looking at past instances where IDYA's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.

Following a +4.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDYA advanced for three days, in 217 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

IDYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IDYA as a result. In 81 of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDYA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for IDYA entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (3.498). P/E Ratio (-16.271) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (14.409) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. IDYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
ATYR vs IDYA: Fundamental Ratings
ATYR
IDYA
OUTLOOK RATING
1..100
2012
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
9160
P/E GROWTH RATING
1..100
10030
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (11) in the null industry is significantly better than the same rating for ATYR (89). This means that IDYA’s stock grew significantly faster than ATYR’s over the last 12 months.

IDYA's Profit vs Risk Rating (80) in the null industry is in the same range as ATYR (100). This means that IDYA’s stock grew similarly to ATYR’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as ATYR (99). This means that IDYA’s stock grew similarly to ATYR’s over the last 12 months.

IDYA's Price Growth Rating (60) in the null industry is in the same range as ATYR (91). This means that IDYA’s stock grew similarly to ATYR’s over the last 12 months.

IDYA's P/E Growth Rating (30) in the null industry is significantly better than the same rating for ATYR (100). This means that IDYA’s stock grew significantly faster than ATYR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRIDYA
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 9 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ATYR: $6.77 vs. IDYA: $32.72)
Brand notoriety: ATYR and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 45% vs. IDYA: 81%
Market capitalization -- ATYR: $622.86M vs. IDYA: $3.01B
ATYR [@Biotechnology] is valued at $622.86M. IDYA’s [@Biotechnology] market capitalization is $3.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green while IDYA’s FA Score has 2 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 2 green, 3 red.
According to our system of comparison, IDYA is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 5 bullish TA indicator(s).

  • ATYR’s TA Score: 5 bullish, 3 bearish.
  • IDYA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ATYR and IDYA are a good buy in the short-term.

Price Growth

ATYR (@Biotechnology) experienced а +9.55% price change this week, while IDYA (@Biotechnology) price change was +1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

ATYR is expected to report earnings on Mar 18, 2027.

IDYA is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-10.45%
AMLX - ATYR
39%
Loosely correlated
+2.88%
IDYA - ATYR
39%
Loosely correlated
+3.04%
NTLA - ATYR
38%
Loosely correlated
+2.15%
OCUL - ATYR
35%
Loosely correlated
+0.76%
IPSC - ATYR
35%
Loosely correlated
+3.57%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+3.04%
RNA - IDYA
48%
Loosely correlated
-3.28%
SLDB - IDYA
47%
Loosely correlated
+6.00%
EDIT - IDYA
45%
Loosely correlated
-4.99%
DYN - IDYA
44%
Loosely correlated
+0.39%
MGTX - IDYA
44%
Loosely correlated
+0.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRM0.280.01
+5.48%
MEDIROM Healthcare Technologies
DVA183.504.22
+2.35%
DaVita
PTLO7.090.11
+1.58%
Portillo's
TRN30.15-0.03
-0.10%
Trinity Industries
NTWK6.89-0.11
-1.57%
NetSol Technologies